Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Bio Key International (BKYI) Capital Expenditures (2016 - 2025)

Bio Key International (BKYI) has disclosed Capital Expenditures for 15 consecutive years, with $1325.0 as the latest value for Q3 2025.

Quarterly Capital Expenditures fell 93.74% to $1325.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$2627.0 through Sep 2025, down 110.92% year-over-year, with the annual reading at $13047.0 for FY2024, 1204.7% up from the prior year.
Capital Expenditures hit $1325.0 in Q3 2025 for Bio Key International, down from $1478.0 in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $50974.0 in Q4 2022 to a low of -$10000.0 in Q4 2024.
Historically, Capital Expenditures has averaged $9698.9 across 5 years, with a median of $4459.0 in 2022.
Biggest five-year swings in Capital Expenditures: soared 1130.96% in 2022 and later plummeted 1100.0% in 2024.
Year by year, Capital Expenditures stood at $4141.0 in 2021, then skyrocketed by 1130.96% to $50974.0 in 2022, then plummeted by 98.04% to $1000.0 in 2023, then tumbled by 1100.0% to -$10000.0 in 2024, then skyrocketed by 113.25% to $1325.0 in 2025.
Business Quant data shows Capital Expenditures for BKYI at $1325.0 in Q3 2025, $1478.0 in Q2 2025, and $4570.0 in Q1 2025.